NCT01686932View on ClinicalTrials.gov

Vildagliptin vs Sitagliptin add-on to Insulin - Impact on Glycemic Profile and Correlation of Hypoglycemic Episodes and Heart Function

PHASE4CompletedINTERVENTIONAL
Enrollment

51

Participants

Timeline

Start Date

November 30, 2012

Primary Completion Date

September 30, 2014

Study Completion Date

September 30, 2014

Conditions
Diabetes Mellitus Type 2
Interventions
DRUG

Vildagliptin

vildagliptin 50mg BID for 8 weeks

DRUG

Sitagliptin

sitagliptin 100mg QD for 8 weeks

Trial Locations (11)

10115

Novartis Investigative Site, Berlin

13055

Novartis Investigative Site, Berlin

14469

Novartis Investigative Site, Potsdam

14612

Novartis Investigative Site, Falkensee

39112

Novartis Investigative Site, Magdeburg

41460

Novartis Investigative Site, Neuss

44137

Novartis Investigative Site, Dortmund

92237

Novartis Investigative Site, Sulzbach-Rosenberg

94574

Novartis Investigative Site, Wallerfing

01307

Novartis Investigative Site, Dresden

04910

Novartis Investigative Site, Elsterwerda

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY